Community-acquired serious bacterial infections in the first 90 days of life: a revisit in the era of multi-drug-resistant organisms
Authors:
- 22 June 2019
- journal article
- research article
- Published by Springer Nature in World Journal of Pediatrics
- Vol. 15 (6) , 580-585
Abstract
Infants in the first 90 days of life are more prone to develop serious bacterial infections (SBIs). Multi-drug-resistant organisms (MDROs) are emerging as important pathogens causing SBIs. We reviewed the epidemiology of SBIs in infants 0–90 days old and compared the clinical features, laboratory values and final outcome for SBIs due to MDROs vs. non-MDROs.Keywords
This publication has 25 references indexed in Scilit:
- Effectiveness of Intrapartum Antibiotic Prophylaxis for Prevention of Early-Onset Group B Streptococcal DiseaseObstetrics & Gynecology, 2013
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistanceClinical Microbiology and Infection, 2012
- Changing Epidemiology of Bacteremia in Infants Aged 1 Week to 3 MonthsPediatrics, 2012
- Preparing Future Pediatricians: Making Time CountPediatrics, 2011
- Urinary Tract Infection: Clinical Practice Guideline for the Diagnosis and Management of the Initial UTI in Febrile Infants and Children 2 to 24 MonthsPediatrics, 2011
- Neonatal sepsisPaediatrics and Child Health, 2011
- Multidrug Resistant Acinetobacter baumannii: Risk Factors for Appearance of Imipenem Resistant Strains on Patients Formerly with Susceptible StrainsPLOS ONE, 2010
- Risk Factors for Serious Bacterial Infection in Febrile Young Infants in a Community Referral HospitalJournal of Korean Medical Science, 2009
- Multidrug Resistance in Pediatric Urinary Tract InfectionsMicrobial Drug Resistance, 2006
- Risk of resistant infections with Enterobacteriaceae in hospitalized neonatesThe Pediatric Infectious Disease Journal, 2002